Funding for this research was provided by:
Cytori Therapeutics LLC (K61010028)
Article History
Received: 14 April 2025
Accepted: 3 October 2025
First Online: 7 November 2025
Declarations
:
: All experimental protocols were approved by the Medical Ethics Committee of Nanfang Hospital, Southern Medical University (approval No. NFEC-2024-296; June 19, 2024) under the ethics review protocol titled "Comparative Study on the Composition and Function of Adipose-Derived Regenerative Cells (ADRCs) Extracted by Celution® 800 and Stromal Vascular Fraction (SVF) Cells Obtained Through Different Methodological Approaches". This approval is applicable to the use of human specimens and animal research.
: Not applicable.
: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.